Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12,318 GBX | -0.42% | +2.22% | +16.21% |
13/05 | AstraZeneca Sued by Trial Participant For Alleged Injury During COVID-19 Vaccine Study | MT |
13/05 | AstraZeneca Sued by Trial Participant For Alleged Injury During COVID-19 Vaccine Study | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.21% | 24TCr | |
+29.98% | 68TCr | |
+30.34% | 57TCr | |
-3.52% | 36TCr | |
+18.59% | 33TCr | |
+4.07% | 28TCr | |
+9.66% | 21TCr | |
-6.83% | 20TCr | |
+7.09% | 17TCr | |
-1.22% | 16TCr |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- ASTRAZENECA : Deutsche Bank reiterates its Sell rating